MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer

被引：21

作者：

Laura Esserman

Elizabeth Kaplan

Savanah Partridge

Debasish Tripathy

Hope Rugo

John Park

Shelley Hwang

Henry Kuerer

Dan Sudilovsky

Ying Lu

Nola Hylton

机构：

[1] University of California,Department of Surgery

[2] University of California,Department of Bioengineering

[3] University of California,Department of Pathology

[4] University of California,Department of Radiology

[5] University of California,Department of Medicine

来源：

Annals of Surgical Oncology | 2001年 / 8卷 / 6期

关键词：

Magnetic resonance imaging; Neoadjuvant chemotherapy; Locally advanced breast cancer;

D O I：

10.1007/s10434-001-0549-8

中图分类号：

学科分类号：

摘要：

Background: The preferred management for women with stage II or locally advanced breast cancer (LABC) is neoadjuvant chemotherapy. Pathologic response to chemotherapy has been shown to be an excellent predictor of outcome. Surrogates that can predict pathologic response and outcome will fuel future changes in management. Magnetic resonance imaging (MRI) demonstrates that patients with LABC have distinct tumor patterns. We investigated whether or not these patterns predict response to therapy.

引用

页码：549 / 559

页数：10

共 119 条

[11]

Hilbertz T(1993)Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI Magn Reson Imaging 11 617-620

[12]

Eiermann W(1993)Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging Radiology 187 751-755

[13]

Permanetter W(1993)Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients Radiology 188 473-478

[14]

Revel D(1988)[Dynamic contrast medium studies with flash sequences in nuclear magnetic resonance tomography of the breast] Digitale Bilddiagn 8 7-13

[15]

Brasch RC(1991)Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast AJR Am J Roentgenol 157 267-270

[16]

Paajanen H(1994)MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique Radiology 193 777-781

[17]

Pierce WB(1995)Benign and malignant breast lesions: differentiation with echo-planar MR imaging Radiology 197 33-38

[18]

Harms SE(1999)Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging J Clin Oncol 17 110-119

[19]

Flamig DP(1996)Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging Cancer 78 91-100

[20]

Griffey RH(1996)Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography Breast Cancer Res Treat 37 1-9

← 1 2 3 4 5 6 7 8 9 10 →